triple glp-1/gip/glucagon receptor agonist retatrutide mechanism glp-1 gip glucagon ly3437943 Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence A once-daily GLP-1/GIP/glucagon receptor tri-agonist

An area of interest is iPSC-derived regulatory T-cells or tolerogenic dendritic cells for transplant surgeries they could promote immune regulation and possibly carry better mitochondria if pre-conditioned in culture (theres evidence that culture conditions can improve mitochondrial health of cells)

Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE

Youll see some folks call it the "dream team" for skin glow and even tone

This class of injectable peptides has gotten attention because growth hormone (GH) levels decrease with age, and lower levels have been linked to troublesome symptoms like weight gain, muscle loss, and difficulty sleeping, among others

Y.BadshahH.RehmanS